These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 37600773)

  • 1. Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies.
    Zhou M; Tang Y; Xu W; Hao X; Li Y; Huang S; Xiang D; Wu J
    Front Immunol; 2023; 14():1140463. PubMed ID: 37600773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.
    Wood LM; Paterson Y
    Front Cell Infect Microbiol; 2014; 4():51. PubMed ID: 24860789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current advances in bacteria-based cancer immunotherapy.
    Guo C; Liu J; Zhang Y
    Eur J Immunol; 2024 Feb; 54(2):e2350778. PubMed ID: 38105295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteria-cancer interactions: bacteria-based cancer therapy.
    Duong MT; Qin Y; You SH; Min JJ
    Exp Mol Med; 2019 Dec; 51(12):1-15. PubMed ID: 31827064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.
    Zhang M; Kim JA; Huang AY
    Front Immunol; 2018; 9():341. PubMed ID: 29535722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanosized drug delivery systems modulate the immunosuppressive microenvironment to improve cancer immunotherapy.
    Yan WL; Lang TQ; Yuan WH; Yin Q; Li YP
    Acta Pharmacol Sin; 2022 Dec; 43(12):3045-3054. PubMed ID: 36050519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.
    Naseri M; Bozorgmehr M; Zöller M; Ranaei Pirmardan E; Madjd Z
    Oncoimmunology; 2020 Jun; 9(1):1779991. PubMed ID: 32934883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of cancer immunotherapy: DNA vaccines leading the way.
    Pandya A; Shah Y; Kothari N; Postwala H; Shah A; Parekh P; Chorawala MR
    Med Oncol; 2023 Jun; 40(7):200. PubMed ID: 37294501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
    Yang J; Zhang C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Vaccines for Cancer Immunotherapy.
    Wang J; Mamuti M; Wang H
    ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium.
    Guo Y; Chen Y; Liu X; Min JJ; Tan W; Zheng JH
    Cancer Lett; 2020 Jan; 469():102-110. PubMed ID: 31666180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical Strategies to Boost Cancer Vaccines.
    Li WH; Li YM
    Chem Rev; 2020 Oct; 120(20):11420-11478. PubMed ID: 32914967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy.
    Lei L; Huang D; Gao H; He B; Cao J; Peppas NA
    Sci Adv; 2022 Nov; 8(47):eadc8738. PubMed ID: 36427310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting innate sensing in the tumor microenvironment to improve immunotherapy.
    Liu Z; Han C; Fu YX
    Cell Mol Immunol; 2020 Jan; 17(1):13-26. PubMed ID: 31844141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
    Qi J; Jin F; Xu X; Du Y
    Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?
    Sharma S; Sharma H; Gogoi H
    Front Immunol; 2023; 14():1277677. PubMed ID: 38090593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A spontaneous multifunctional hydrogel vaccine amplifies the innate immune response to launch a powerful antitumor adaptive immune response.
    Liang X; Li L; Li X; He T; Gong S; Zhu S; Zhang M; Wu Q; Gong C
    Theranostics; 2021; 11(14):6936-6949. PubMed ID: 34093863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.